CEREBYX Injection is a clear, colorless to pale yellow solution supplied as follows:
| mg phenytoin sodium equivalents (PE) per vial | Volume per vial (mL) | Package Configuration | NDC |
|---|---|---|---|
500 mg PE/10 mL vial | 10 mL per vial | Package contains 10 vials of NDC 0069-6001-10 | NDC 0069-6001-21 |
100 mg PE/2 mL vial | 2 mL per vial | Package contains 25 vials of NDC 0069-6001-02 | NDC 0069-6001-25 |
Both sizes of vials contain Tromethamine, USP (TRIS), Hydrochloric Acid, NF, or Sodium Hydroxide, NF, and Water for Injection, USP.
CEREBYX should always be prescribed in phenytoin sodium equivalents (PE) [see Dosage and Administration (2.1) and Warnings and Precautions (5.1)].
1.5 mg of fosphenytoin sodium is equivalent to 1 mg phenytoin sodium, and is referred to as 1 mg PE. The amount and concentration of fosphenytoin is always expressed in terms of mg of phenytoin sodium equivalents (PE). Fosphenytoin's weight is expressed as phenytoin sodium equivalents to avoid the need to perform molecular weight-based adjustments when substituting fosphenytoin for phenytoin or vice versa.
Store under refrigeration at 2°C to 8°C (36°F to 46°F). The product should not be stored at room temperature for more than 48 hours. Vials that develop particulate matter should not be used.
Injection vials are single-dose only. After opening, any unused product should be discarded.
CEREBYX Injection is a clear, colorless to pale yellow solution supplied as follows:
| mg phenytoin sodium equivalents (PE) per vial | Volume per vial (mL) | Package Configuration | NDC |
|---|---|---|---|
500 mg PE/10 mL vial | 10 mL per vial | Package contains 10 vials of NDC 0069-6001-10 | NDC 0069-6001-21 |
100 mg PE/2 mL vial | 2 mL per vial | Package contains 25 vials of NDC 0069-6001-02 | NDC 0069-6001-25 |
Both sizes of vials contain Tromethamine, USP (TRIS), Hydrochloric Acid, NF, or Sodium Hydroxide, NF, and Water for Injection, USP.
CEREBYX should always be prescribed in phenytoin sodium equivalents (PE) [see Dosage and Administration (2.1) and Warnings and Precautions (5.1)].
1.5 mg of fosphenytoin sodium is equivalent to 1 mg phenytoin sodium, and is referred to as 1 mg PE. The amount and concentration of fosphenytoin is always expressed in terms of mg of phenytoin sodium equivalents (PE). Fosphenytoin's weight is expressed as phenytoin sodium equivalents to avoid the need to perform molecular weight-based adjustments when substituting fosphenytoin for phenytoin or vice versa.
Store under refrigeration at 2°C to 8°C (36°F to 46°F). The product should not be stored at room temperature for more than 48 hours. Vials that develop particulate matter should not be used.
Injection vials are single-dose only. After opening, any unused product should be discarded.
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.